Previous close | 4.1000 |
Open | 3.7000 |
Bid | 3.4000 |
Ask | 3.8000 |
Strike | 87.50 |
Expiry date | 2023-04-21 |
Day's range | 3.7000 - 3.7000 |
Contract range | N/A |
Volume | |
Open interest | 701 |
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Bicycle (BCYC) and Novartis enter into a collaboration agreement to develop, manufacture and commercialize conjugate drugs for several oncology indications. Stock soars following the news.
Novartis (NVS) Kisqali meets primary endpoint of invasive disease-free survival in certain patients with early breast cancer at risk of recurrence.